INNOVATION SPRINT
Find your ingredient’s
next revenue opportunity.
Identify and prioritise new applications and markets for ingredients already in your portfolio. Give your commercial and scientific teams a clear direction for the next investment.
Discuss your ingredientCONCRETE OUTPUTS. A CLEARER DECISION.
Know where your ingredient
can grow and what to do next.
Growth Opportunity Map
Where could your ingredient go next?Known and potential new applications, ranked by scientific support and commercial potential. Clear rationale and key uncertainties for each opportunity.
Evidence, Claims & Protection Roadmap
What would make the opportunity credible?Assess regulatory requirements, health-claim pathways and IP opportunities. Receive recommended studies and protection options, including draft patent claims where relevant.
Commercial Action Plan
What should your team do next?Identify priority customer segments, prospective customers and partners. Define competitive positioning and practical next steps for the selected applications.
The work packages, timeline and deliverables are agreed around your ingredient and business question.
CLIENT CASE / METABOLIC HEALTH
New product opportunities.
Backed by evidence.
An established ingredient. A need for new applications and growth opportunities.
Identified suitable metabolic health products and synergies with key formulation ingredients, giving the supplier concrete opportunities for new formulations.
Validated findings experimentally and drafted and filed patent claims to support the next stage of proprietary product development.
SCIENCE CONNECTED TO BUSINESS
AI explores.
Experts assess.
Our virtual cell technology connects ingredient chemistry, existing data and scientific literature to biological endpoints. Our experts assess the predictions and evidence, then translate the findings into commercially relevant applications.
Explore the technologyLET’S MOVE FORWARD
What else could your ingredient do?
Bring an ingredient and a business question. We’ll discuss a focused scope.
